Gunnel Biberfeld
Biberfeld, Gunnel, 1936-
Biberfeld, Gunnel, 19..-....
Biberfeld, Gunnel
VIAF ID: 41809647 (Personal)
Permalink: http://viaf.org/viaf/41809647
Preferred Forms
-
-
100 1 _ ‡a Biberfeld, Gunnel, ‡d 19..-....
-
100 1 _ ‡a Biberfeld, Gunnel, ‡d 1936-
-
100 0 _ ‡a Gunnel Biberfeld
-
100 0 _ ‡a Gunnel Biberfeld
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation |
![]() |
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial |
![]() |
Clinical progression in early and late stages of disease in a cohort of individuals infected with human immunodeficiency virus-2 in Guinea-Bissau |
![]() |
Comparison of the performance of rapid HIV tests using samples collected for surveillance in Mozambique |
![]() |
Cytodiagnosis of thyroiditis : a comparative study of cytological, histological, immunological and clinical findings in thyroiditis, particularly in diffuse lymphoid thyroiditis |
![]() |
Dichotomy between CD1a+ and CD83+ dendritic cells in lymph nodes during SIV infection of macaques. |
![]() |
Evaluation of an alternative confirmatory strategy for the diagnosis of HIV infection in Dar Es Salaam, Tanzania, based on simple rapid assays |
![]() |
High sexual risk taking and diverging trends of HIV-1 and HIV-2 in the military of Guinea Bissau |
![]() |
HIV-1 infection prevalence and incidence trends in areas of contrasting levels of infection in the Kagera region, Tanzania, 1987-2000. |
![]() |
Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques. |
![]() |
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques. |
![]() |
Immunological, epidemiological and ultrastructural studies of mycoplasm pneumoniae |
![]() ![]() |
Incidence of HIV and the prevalence of HIV, hepatitis B and syphilis among youths in Maputo, Mozambique: a cohort study |
![]() |
Innate immunity in experimental SIV infection and vaccination |
![]() |
A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice |
![]() |
A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry |
![]() |
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults |
![]() |
Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen |
![]() |
The prevalence and pattern of skin diseases in relation to CD4 counts among HIV-infected police officers in Dar es Salaam |
![]() |
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial |
![]() |
Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania |
![]() |
Slow progression of HIV-1 infection in a cohort of antiretroviral naïve hotel workers in Dar es Salaam, Tanzania as defined by their CD4 cell slopes |
![]() |
Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes |
![]() |
Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers |
![]() |
Treatment of Kaposi sarcoma in human immunodeficiency virus-1-infected Mozambican children with antiretroviral drugs and chemotherapy |
![]() |
Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999. |
![]() |
Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania |
![]() |
Women's preferences regarding infant or maternal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV during breastfeeding and their views on Option B+ in Dar es Salaam, Tanzania |
![]() |